Previous close | 0.2000 |
Open | 0.1800 |
Bid | 0.0000 |
Ask | 0.5000 |
Strike | 2.50 |
Expiry date | 2024-06-21 |
Day's range | 0.1800 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 40 |
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today announced that management will participate in the Truist Securities MedTech Conference, which is being held at the InterContinental Boston in Boston, MA on Tuesday, June 18th. Management will participate in 1x
Organogenesis Holdings ( NASDAQ:ORGO ) First Quarter 2024 Results Key Financial Results Revenue: US$110.0m (up 2.2...
ORGO's Q1 Earnings Overview: Surpasses Revenue Forecasts Amidst Challenges